Incidence of hypersensitivity and anaphylaxis with sugammadex
Incidence of hypersensitivity and anaphylaxis with sugammadex
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
To evaluate the incidence of hypersensitivity and anaphylaxis after administration of sugammadex.
Retrospective analysis.
Sugammadex clinical development program and post-marketing experience.
Surgical patients and healthy volunteers who received sugammadex or placebo/comparator with anesthesia and/or neuromuscular blockade (NMB).
Sugam...
Alternative Titles
Full title
Incidence of hypersensitivity and anaphylaxis with sugammadex
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2022994212
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2022994212
Other Identifiers
ISSN
0952-8180,1873-4529
E-ISSN
1873-4529
DOI
10.1016/j.jclinane.2018.03.018
